Kirkland & Ellis represented Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, on its acquisition of Alcresta Therapeutics, Inc., a leader in commercializing novel enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases. Read Linden’s press release The Kirkland team was led by corporate partners Brett Nelson and Robert Wilson; tax partner Chris Worek; and debt finance partners Thomas Dobleman and Daniel Schwimmer.